865746

Azurity Pharmaceuticals, Inc. — FEI 3003395329

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 29, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Woburn, MA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)